Related Experiment Video
Updated: Jun 3, 2025
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Recurrent atrial fibrillation markers post radiofrequency catheter ablation
Rangrang Zhang1, Qingyuan Cai2, Dongpu Shao2
1Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Hypertension Institute, NHC Key Laboratory of Hypertension Clinical Research, Key Laboratory of Xinjiang Uygur Autonomous Region, Hypertension Research Laboratory, Xinjiang Clinical Medical Research Center for Hypertension (Cardio-Cerebrovascular) Diseases, Urumqi, Xinjiang 830001, China.
Insights
Atrial fibrillation (AF) recurrence after catheter ablation (CA) is common. Identifying early markers for AF recurrence can help guide post-procedure treatments and improve patient outcomes.
Area of Science:
- Cardiology
- Biomedical Science
- Medical Technology
Background:
- Atrial fibrillation (AF) is the most prevalent heart arrhythmia and a significant risk factor for stroke.
- Catheter ablation (CA) is an effective treatment for AF, but high recurrence rates persist post-procedure.
- Early identification of patients at risk for AF recurrence is crucial for optimizing treatment strategies.
Purpose of the Study:
- To review and categorize markers associated with atrial fibrillation recurrence after catheter ablation.
- To explore biochemical, imaging, and electrocardiographic markers for predicting AF recurrence.
- To highlight the need for early identification of patients prone to AF recurrence for tailored post-ablation management.
Main Methods:
- Literature review of studies reporting on atrial fibrillation recurrence markers.
- Categorization of identified markers into biochemical, imaging, and electrocardiographic types.
- Synthesis of current knowledge on the predictive value of these markers.
Main Results:
- Biochemical markers, imaging findings, and electrocardiographic parameters have been investigated as predictors of AF recurrence.
- These markers offer potential for early identification of patients likely to experience AF recurrence post-CA.
- A comprehensive understanding of these markers can guide therapeutic decisions.
Conclusions:
- Biochemical, imaging, and electrocardiographic markers show promise in predicting atrial fibrillation recurrence after catheter ablation.
- Utilizing these markers can facilitate personalized treatment strategies, including anti-inflammatory or antiarrhythmic therapies.
- Further research and validation are needed to integrate these markers into routine clinical practice for improved AF management.
Abstract:
Atrial fibrillation (AF), the most common type of heart arrhythmia, is recognized as an independent risk factor for stroke. Fortunately, catheter ablation (CA) offers an effective treatment option for AF patients. However, numerous studies have reported suboptimal outcomes, as AF recurrence rates often remain elevated even after CA. Consequently, there exists a need for early identification of patients prone to recurrence, necessitating anti-inflammatory and/or antiarrhythmic treatment post-CA. The discovery and application of markers associated with AF recurrence could significantly aid in this early identification process. In this review, we present an overview of AF recurrence markers from three distinct perspectives (biochemical, imaging, and electrocardiographic markers).
